Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Central Nervous System (CNS) therapeutics Market Research Reports
Central Nervous System (CNS) therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... s comprehensive information on the therapeutics under development for Creutzfeldt Jakob Disease , complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also......" | 30-Apr-2021 | $2000 | |
Postherpetic Neuralgia (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... ensive information on the therapeutics under development for Postherpetic Neuralgia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the d......" | 30-Apr-2021 | $2000 | |
Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... information on the therapeutics under development for Musculoskeletal Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descripti......" | 30-Apr-2021 | $2000 | |
Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... s (PPMS) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Primary Progressive Multiple Sclerosis (PPMS), complete with analysis by Stage of Development, Drug Target, Mechanism of......" | 30-Apr-2021 | $2000 | |
Psychosis (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... under development for Psychosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutic......" | 30-Apr-2021 | $2000 | |
Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... >
The report provides comprehensive information on the therapeutics under development for Relapsing Multiple Sclerosis (RMS), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA)......" | 30-Apr-2021 | $2000 | |
Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... s (RRMS) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with analysis by Stage of Development, Drug Target, Mechanism of......" | 30-Apr-2021 | $2000 | |
Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Anorexia Nervosa, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacologic......" | 30-Apr-2021 | $2000 | |
Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... rovides comprehensive information on the therapeutics under development for Appetite (Eating) Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The repo......" | 30-Apr-2021 | $2000 | |
Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Circadian Rhythm Sleep Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Mol......" | 30-Apr-2021 | $2000 | |
| | |||